Goldman Sachs Starts Phathom Pharmaceuticals (PHAT) at Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. LITE
4. PLTR
5. REGN
6. MRVL
7. ABBV
8. CL
9. CHKP
10. TFII

Go back to Goldman Sachs Starts Phathom Pharmaceuticals (PHAT) at Neutral

Evercore ISI Starts Phathom Pharmaceuticals (PHAT) at Outperform

November 19, 2019 8:27 PM EST

Evercore ISI analyst Umer Raffat initiates coverage on Phathom Pharmaceuticals (NASDAQ: PHAT) with a Outperform rating.

For an analyst ratings summary and ratings history on Phathom Pharmaceuticals click here. For more ratings news on Phathom Pharmaceuticals click here.

Shares of Phathom Pharmaceuticals closed at $24.27 yesterday.

... More

Needham & Company Starts Phathom Pharmaceuticals (PHAT) at Buy, Street High $40 PT

November 19, 2019 7:45 AM EST

Needham & Company analyst Alan Carr initiates coverage on Phathom Pharmaceuticals (NASDAQ: PHAT) with a Buy rating and a price target of $40.00.

The analyst comments "Phathom is developing vonoprazan, a novel oral potassium-competitive acid blocker (PCAB) for the treatment of Erosive Esophagitis... More